- Home
- ATRC
ATRC
AtriCure Inc.
as 11-22-2024 4:00pm EST
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MASON |
| Market Cap: | 1.1B | IPO Year: | 2005 |
| Target Price: | $43.11 | AVG Volume (30 days): | 736.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.94 - $42.99 | Next Earning Date: | 10-29-2024 |
| Revenue: | $447,573,000 | Revenue Growth: | 17.56% |
| Revenue Growth (this year): | 17.75% | Revenue Growth (next year): | 13.44% |
Latest AtriCure Inc. News
ATRC Breaking Stock News: Dive into ATRC Ticker-Specific Updates for Smart Investing
Business Wire
4 days ago
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
Business Wire
17 days ago
AtriCure to Participate in the Stifel 2024 Healthcare Conference
Simply Wall St.
23 days ago
US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results
Simply Wall St.
24 days ago
AtriCure Third Quarter 2024 Earnings: Beats Expectations
MT Newswires
24 days ago
UBS Adjusts Price Target on AtriCure to $40 From $35, Maintains Buy Rating
Thomson Reuters StreetEvents
24 days ago
Q3 2024 AtriCure Inc Earnings Call
GuruFocus.com
25 days ago
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges
Zacks
25 days ago
AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Compare ATRC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATRC AtriCure Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.